< Back to previous page
Researcher
Ghesquiere Bart
- Disciplines (Flanders Institute for Biotechnology):Analysis of next-generation sequence data, Cell death, Cancer biology, (Bio)molecular modelling and design, Analytical biochemistry, Auto-ecology, Biogeography and phylogeography, Anthropological genetics, Bacteriology, Cell death and senescence, Epigenomics, Environmental safety and health of nanotechnology, Medical biophysics, General diagnostics, Adaptive immunology, Behavioural neuroscience
- Disciplines (KU Leuven):Metabolomics, Separation techniques, Spectrometry, Regulation of metabolism
- See also: Bart Ghesquière (KU Leuven)
Affiliations
- Metabolomics Expertise Center (VIB-KU Leuven) (Division)
Responsible
From1 Oct 2016 → Today - VIB Metabolomics Core Leuven (Core Lab)
Responsible
From1 Sep 2017 → Today - VIB-KU Leuven Center for Cancer Biology (Research Center)
Responsible
From1 Sep 2017 → Today - Ghesquière Lab (Research group)
Responsible
From1 Sep 2017 → Today - VIB Metabolomics Core Leuven (Core Lab)
Responsible
From1 Jan 2017 → Today - Metabolomics Expertise Center (VIB-KU Leuven) (Division)
Member
From1 Oct 2016 → 30 Sep 2022 - Laboratory of Angiogenesis and Vascular Metabolism (VIB-KU Leuven) (Division)
Member
From1 Jan 2012 → 30 Sep 2014
Projects
1 - 5 of 5
- Tracer Raman-Driven Mass Spectrometry Imaging (TRaMaSI): a new platform for on-tissue Tracing of Nutritional and Biochemical Trajectories.From1 May 2024 → TodayFunding: HORIZON.1.2 - Marie Skłodowska-Curie-actions (MSCA)
- VIB Grant for Ghesquière Lab_Period:2022-01-01-2026-12-31From1 Jan 2022 → TodayFunding: FRI - Project driven research
- BE19-COMMUNITYLED (Bestaat uit de projecten GALAXY en PLANTS en gedeelte voor BaGh)From1 Jun 2019 → 31 May 2021Funding: EMBL
- 'Advancing a Precision Medicine Paradigm in metastatic Colorectal Cancer: Systems based patient stratification solutions’ — ‘COLOSSUS’From1 Jan 2018 → 31 Dec 2022Funding: Other EU initiatives out of framework
- VIB Grant for Ghesquière Lab_Period:2018-01-01-2021-12-31From1 Jan 2018 → 31 Dec 2021Funding: FRI - Project driven research
Publications
11 - 20 of 75
- NRF2 Activation Reprograms Defects in Oxidative Metabolism to Restore Macrophage Function in Chronic Obstructive Pulmonary Disease.(2023)
Authors: Wesley Vermaelen, Bart Ghesquière, Peter Carmeliet
Pages: 998-1011 - Mitochondrial adaptation decreases drug sensitivity of persistent triple negative breast cancer cells surviving combinatory and sequential chemotherapy.(2023)
Authors: Bart Ghesquière
Pages: 100949 - Tracer metabolomics reveals the role of aldose reductase in glycosylation.(2023)
Authors: Silvia Radenkovic, Karen Driesen, Bart Ghesquière
Pages: 101056 - A mouse model of hepatic encephalopathy: bile duct ligation induces brain ammonia overload, glial cell activation and neuroinflammation.(2022)
Authors: Wouter Claeys, Lien Van Hoecke, Bart Ghesquière, Roosmarijn Vandenbroucke
Pages: 17558 - Unraveling metabolism during kidney perfusion using tracer studies: a systematic review.(2022)
Authors: Julie De Beule, Bart Ghesquière
Pages: 2118-2134 - RRM2 enhances MYCN-driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition.(2022)
Authors: Bart Ghesquière, Sven Eyckerman
Pages: eabn1382 - Skeletal progenitors preserve proliferation and self-renewal upon inhibition of mitochondrial respiration by rerouting the TCA cycle.(2022)
Authors: Gianmarco Rinaldi, Guy Eelen, Peter Carmeliet, Bart Ghesquière, Sarah-Maria Fendt
Pages: 111105 - Antizyme Inhibitor 1 regulates matrikine expression and enhances the metastatic potential of aggressive primary prostate cancer.(2022)
Authors: Bram Boeckx, Diether Lambrechts, Bart Ghesquière, Roy Eerlings
Pages: 527-541 - Pyrroline-5-Carboxylate Reductase 1: a novel target for sensitizing multiple myeloma cells to bortezomib by inhibition of PRAS40-mediated protein synthesis.(2022)
Authors: Bart Ghesquière
Pages: 45 - The glucose transporter GLUT3 controls T helper 17 cell responses through glycolytic-epigenetic reprogramming.(2022)
Authors: Bart Ghesquière
Pages: 516-532.e11
Patents
1 - 5 of 5
- METHODS FOR ANALYZING THE PERFUSATE OF AN EX SITU MACHINE PERFUSED KIDNEY (Inventor)
- Methods and Materials for Treating Glycosylation Disorders (Inventor)
- Methods and Materials for Treating Glycosylation Disorders (Inventor)
- Methods and Materials for Treating Glycosylation Disorders (Inventor)
- Methods and Materials for Treating Glycosylation Disorders (Inventor)